Dextroamp-amphet ER 30 MG cap 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F0L17
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,022
Award facts
- Contract value 100% obligated
- $1,021.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a ceiling value of $1,021.84. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support Department of Defense healthcare programs. This delivery order for controlled pharmaceutical substances represents one of numerous competitive awards issued under the prime contract, demonstrating AmerisourceBergen's capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0L17?
SPE2DR26F0L17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F0L17 worth?
The government has obligated $1,022 on SPE2DR26F0L17.
Is contract SPE2DR26F0L17 an order under another contract?
Yes. SPE2DR26F0L17 is a delivery order under SPE2DR25D2207, an indefinite delivery contract.
Was contract SPE2DR26F0L17 competed?
The extent of competition for SPE2DR26F0L17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award